InterMune Inc - ITMN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

InterMune Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ITMN	Nasdaq	2834	http://www.intermune.com	9.58 -0.38
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for InterMune Inc Commit To Buy InterMune At $5, Earn 44.6% - May 23rd, 2013 12:15 pm SAC Digs In as Deadline Nears for U.S. Insider Cases - May 20th, 2013 2:40 am INTERMUNE INC Financials - May 11th, 2013 11:04 am Kyrgyzstan Decries Dismissal of U.S. Case Against Bakiyev - May 10th, 2013 5:32 pm U.S. Case Ends Against Ex-Kyrgyz Leader Bakiyev’s Son - May 9th, 2013 6:52 pm REUTERS SUMMIT-Drugmakers split as demands for open data mount - May 8th, 2013 8:16 am After AbbVie's Humira: What Next? - May 6th, 2013 2:45 pm INTERMUNE INC Files SEC form 10-Q, Quarterly Report - May 6th, 2013 8:20 am 2 Biotechs To Avoid, 1 To Buy - May 4th, 2013 8:29 am Positive News in the Oncology Space Regarding Myeloma and Melanoma Drugs: Expert Analyst Boris Peaker Discusses Recent Successes for Biotechnology Companies - May 1st, 2013 9:15 am UPDATE 2-Europe's regulator digs in for drug data fight - Apr 30th, 2013 1:04 pm CORRECTED-Court stops EU regulator releasing drug company data - Apr 30th, 2013 12:34 pm UPDATE 1-Europe's regulator digs in for drug data fight - Apr 30th, 2013 9:13 am Court stops EU regulator releasing drug company data - Apr 30th, 2013 6:30 am ITMN Crosses Above Key Moving Average Level - Apr 29th, 2013 2:51 pm Sarepta (SRPT) Targets Unmet Medical Need in the Treatment of Duchenne Muscular Dystrophy; Developing First Drug with the Promise of Stopping Fatal Progressive Disease - Apr 29th, 2013 9:07 am Hedge funds are buying these stocks - Apr 26th, 2013 2:41 pm InterMune Cuts Loss, Affirms View - Apr 25th, 2013 8:40 am InterMune's CEO Discusses Q1 2013 Results - Earnings Call Transcript - Apr 24th, 2013 8:22 pm InterMune Earnings: Everything You Must Know Now - Apr 24th, 2013 6:10 pm View All Current Headlines >>